ConductScience.org, home

Paper27936622

DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.

Stornetta A and 4 others. Chem Res Toxicol, 2017. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine. Papers, record 27936622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27936622

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.
PubMed
Journal
Chem Res Toxicol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
2.31
iCite
Revised in PubMed
2025-05-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stornetta AAlessiahttps://orcid.org/0000-0002-8287-9551
2Zimmermann MMaike
3Cimino GDGeorge D
4Henderson PTPaul T
5Sturla SJShana J

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
DNA AdductsMajor topic
Animals
Biomarkers
Humans
Hypoxia
Nitrogen Mustard Compounds
Oxidoreductases
Platinum Compounds
Precision Medicine
Prodrugs

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA093373NCI NIH HHSUnited StatesP30CA093373PubMed and NIHNIH RePORTER
260341European Research CouncilInternationalPubMedPubMed
P41 RR013461NCRR NIH HHSUnited StatesP41RR013461PubMed and NIHNIH RePORTER
P41 GM103483NIGMS NIH HHSUnited StatesP41GM103483PubMed and NIHNIH RePORTER
680920European Research CouncilInternationalPubMedPubMed

References180

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,510,497Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients.Anticancer Drugs1998https://conductscience.org/library/papers/9510497PubMed
219,737,541ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts.Biochem Pharmacol2010https://conductscience.org/library/papers/19737541PubMed
33,324,117Metabolism and reactions of alkylating agents.Pharmacol Ther1987https://conductscience.org/library/papers/3324117PubMed
410,858,321Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells.Chem Res Toxicol2000https://conductscience.org/library/papers/10858321PubMed
59,288,880Detection of DNA modifications by the 32P-postlabelling assay.Mutat Res1997https://conductscience.org/library/papers/9288880PubMed
624,254,606Ultrasensitive radioisotope, stable-isotope, and trace-element analysis in the biological sciences using tandem accelerator mass spectrometry.Biol Trace Elem Res1987https://conductscience.org/library/papers/24254606PubMed
79,400,943Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.Br J Cancer1997https://conductscience.org/library/papers/9400943PubMed
823,394,702Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Bioanalysis2013https://conductscience.org/library/papers/23394702PubMed
916,178,771Recent advances in understanding and exploiting the activation of anthracyclines by formaldehyde.Curr Med Chem Anticancer Agents2005https://conductscience.org/library/papers/16178771PubMed
1011,476,483DNA minor-groove recognition by small molecules.Nat Prod Rep2001https://conductscience.org/library/papers/11476483PubMed
112,386,792Induction of stable transcriptional blockage sites by adriamycin: GpC specificity of apparent adriamycin-DNA adducts and dependence on iron(III) ions.Biochemistry1990https://conductscience.org/library/papers/2386792PubMed
127,192,601DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.Cancer Res1981https://conductscience.org/library/papers/7192601PubMed
134,993,458Mitomycin derivatives. 2. Derivatives of decarbamoylmitosane and decarbamoylmitosene.J Med Chem1971https://conductscience.org/library/papers/4993458PubMed
1421,793,181Formation of cyclophosphamide specific DNA adducts in hematological diseases.Pediatr Blood Cancer2012https://conductscience.org/library/papers/21793181PubMed
1516,651,442Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.Cancer Res2006https://conductscience.org/library/papers/16651442PubMed
1621,028,869Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.Chem Res Toxicol2010https://conductscience.org/library/papers/21028869PubMed
1717,606,726Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.Clin Cancer Res2007https://conductscience.org/library/papers/17606726PubMed
187,859,370Dose-response studies of MeIQx in rat liver and liver DNA at low doses.Carcinogenesis1995https://conductscience.org/library/papers/7859370PubMed
1912,122,100An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.J Natl Cancer Inst2002https://conductscience.org/library/papers/12122100PubMed
2010,064,864Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts.Mutat Res1999https://conductscience.org/library/papers/10064864PubMed

See all 180 references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42,592,091ADMET Profiling of the Metallodrugs: A Comparative Review of Platinum, Palladium, Gold, Ruthenium, Copper, and Zinc Anticancer Complexes.Bioinorg Chem Appl2026https://conductscience.org/library/papers/42592091PubMed
41,841,497Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage.Nucleic Acids Res2026https://conductscience.org/library/papers/41841497PubMed
41,468,147The Unique Utility of Newborn Dried Blood Spots for Driving Discovery in Childhood Cancer Research.Clin Chem2025https://conductscience.org/library/papers/41468147PubMed
41,127,336Cisplatin resistance in head and neck squamous cell carcinoma is linked to DNA damage response and cell cycle arrest transcriptomics rather than poor drug uptake.Cancer Drug Resist2025https://conductscience.org/library/papers/41127336PubMed
40,767,287Vitamin C as a Cardioprotective Agent Against Doxorubicin-Induced Cardiotoxicity.J Am Heart Assoc2025https://conductscience.org/library/papers/40767287PubMed
40,663,054Evaluating Naphthalene-Modified Metallosalen Complexes as Anticancer Agents.J Med Chem2025https://conductscience.org/library/papers/40663054PubMed
40,513,340Treatment of human cells with the anti-cancer drug cisplatin results in the caspase-dependent release of adduct-containing cell-free DNA.DNA Repair (Amst)2025https://conductscience.org/library/papers/40513340PubMed
40,109,217DNA damage of peripheral blood lymphocytes as a dual biomarker: Diagnostic and treatment response in woman breast cancer patients.Cancer Biomark2025https://conductscience.org/library/papers/40109217PubMed
40,014,449Translesion-synthesis-mediated bypass of DNA lesions occurs predominantly behind replication forks restarted by PrimPol.Cell Rep2025https://conductscience.org/library/papers/40014449PubMed
38,231,175Mass Spectral Library for DNA Adductomics.Chem Res Toxicol2024https://conductscience.org/library/papers/38231175PubMed
37,490,747Liquid Chromatography-Mass Spectrometry Screening of Cyclophosphamide DNA Damage In Vitro and in Patients Undergoing Chemotherapy Treatment.Chem Res Toxicol2023https://conductscience.org/library/papers/37490747PubMed
37,375,269A Comparative Evaluation of the Photosensitizing Efficiency of Porphyrins, Chlorins and Isobacteriochlorins toward Melanoma Cancer Cells.Molecules2023https://conductscience.org/library/papers/37375269PubMed
36,820,303Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy.Mol Ther Oncolytics2023https://conductscience.org/library/papers/36820303PubMed
36,714,466Comparative analysis of chlorambucil-induced DNA lesion formation and repair in a spectrum of different human cell systems.Toxicol Rep2023https://conductscience.org/library/papers/36714466PubMed
36,694,906Bulky Adducts in Clustered DNA Lesions: Causes of Resistance to the NER System.Acta Naturae2022https://conductscience.org/library/papers/36694906PubMed
36,324,163Analysis of N7-(2-carbamoyl-2-hydroxyethyl)guanine in dried blood spot after food exposure by Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry.BMC Chem2022https://conductscience.org/library/papers/36324163PubMed
35,744,887Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro.Molecules2022https://conductscience.org/library/papers/35744887PubMed
34,876,121Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients.BMC Vet Res2021https://conductscience.org/library/papers/34876121PubMed
34,576,304Applications of Adductomics in Chemically Induced Adverse Outcomes and Major Emphasis on DNA Adductomics: A Pathbreaking Tool in Biomedical Research.Int J Mol Sci2021https://conductscience.org/library/papers/34576304PubMed
34,418,576Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.Semin Cancer Biol2021https://conductscience.org/library/papers/34418576PubMed

See all 31 cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27936622

GET https://conductscience.org/api/papers/v1/27936622/references?page=2